Novel blood marker reduces the risk of a false diagnosis of Alzheimer's disease

Alzheimer's disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally stabilizes the structure of nerve cells, but in this disease the protein undergoes chemical changes and begins to form tangles in the neurons. This altered form is known as p-tau217 and can be measured in the blood.